Statistique de GreenBone Ortho Spa

83Dispositifs total

1UDI-DI de base

0Non destinés au marché UE

0Certificats

0Valides

0Expirant < 6 mois

1Pays

Santé des certificats de GreenBone Ortho Spa

Aucun certificat enregistré pour ce fabricant.

Affichage de 76–83 sur 83 dispositifs.

Dénomination commerciale	Numéro de référence/catalogue	Code d'UDI-DI	Quantité	Statut
HC100060PS	`HC100060PS`	`08053848341301`	1	Sur le marché
HC100030PS	`HC100030PS`	`08053848341271`	1	Sur le marché
GR102015PS	`GR102015PS`	`08053848340526`	1	Sur le marché
GR051010PS	`GR051010PS`	`08053848340472`	1	Sur le marché
GR204010PS	`GR204010PS`	`08053848340496`	1	Sur le marché
GR407105PS	`GR407105PS`	`08053848341264`	1	Sur le marché
HC100040PS	`HC100040PS`	`08053848341288`	1	Sur le marché
GR407115PS	`GR407115PS`	`08053848340878`	1	Sur le marché

Dispositifs placés dans 1 pays

Mise à jour MD Atlas : le 27 mai 2026

IT-MF-000033034

Actif

Nom: Ministero della salute - Direzione generale dei dispositivi medici e del servizio farmaceutico
SRN: IT-CA-070
Téléphone: +39 06 5994 3199/ +39 06 5994 3207
Email: segr.dgfdm@sanita.it

BONOMI Vanessa
1) the technical documentation and the EU declaration of conformity are drawn up and kept up-to-date; 2) the post-market surveillance obligations (PMS Plan, PSUR) are complied with in accordance with Article 10(10) 3) to ensure the vigilance reporting obligations referred to in Articles 87 to 91 are fulfilled
Masqué
CHA Andrea
The conformity of the devices is appropriately checked, in accordance with the quality management system under which the devices are manufactured, before a device is released;
Masqué
SALVAGNO Susanna
1) the technical documentation (CEP, CER, SSCP) is drawn up and kept up-to-date; 2) the post-market surveillance obligations (PMCF) are complied with in accordance with Article 10(10) 3) to ensure in the case of devices for performance studies intended to be used in the context of interventional clinical performance studies or other performance studies involving risks for the subjects, the statement referred to in Section 4.1 of Chapter II of Annex XV is issued.
Masqué